Tomas Szotkowski
Olomouc, Czech Republic
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 44 publications
Twenty Years of Therapeutic Leukocytapheresis in Newly Diagnosed Acute Myeloid Leukemia: Insights From A Single Center.
Journal: Journal of clinical apheresis
Published: October 30, 2025
Randomized Comparison of Cardiotoxicity With 60 Versus 90 mg Daunorubicin in AML Induction Therapy.
Journal: American journal of hematology
Published: August 18, 2025
Real-World Experience With Venetoclax-Based Therapy in Acute Myeloid Leukemia: Insights From the Czech Republic.
Journal: Clinical lymphoma, myeloma & leukemia
Published: April 14, 2025
Single or Double Induction With 7 + 3 Containing Standard or High-Dose Daunorubicin for Newly Diagnosed AML: The Randomized DaunoDouble Trial by the Study Alliance Leukemia.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: September 16, 2024
Correction: Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey.
Journal: Infection
Published: May 21, 2024
Fungal infection frequency in newly diagnosed acute myeloid leukaemia patients treated with venetoclax plus azacitidine with or without antifungal prophylaxis.
Journal: British journal of haematology
Published: May 11, 2024
The mortality of COVID-19 in CML patients from 2020 until 2022: results from the EPICOVIDEHA survey.
The mortality of COVID-19 in CML patients from 2020 until 2022: results from the EPICOVIDEHA survey.
Journal: Leukemia & lymphoma
Published: November 15, 2023
Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey.
Journal: Infection
Published: November 10, 2023
Treatment of adult patients with acute lymphoblastic leukemia in the Czech Republic in the period 2007-2020.
Journal: Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti
Published: October 25, 2023
Effectiveness of tixagevimab/cilgavimab in patients with hematological malignancies as a pre-exposure prophylaxis to prevent severe COVID-19: a Czech retrospective multicenter study.
Journal: Annals of hematology
Published: September 17, 2023
Survival in multiple myeloma and SARS-COV-2 infection through the COVID-19 pandemic: Results from the EPICOVIDEHA registry.
Journal: Hematological oncology
Published: June 27, 2023
Last Updated: 09/26/2026